Results 81 to 90 of about 3,780 (219)

Pharmacological evaluation of BAM-1110, a novel dopamine receptor agonist, as an antiparkinson agent.

open access: diamond, 1994
Kenji Ichihara   +3 more
openalex   +1 more source

Innovation and Foreign Investment Behavior of the U.S. Pharmaceutical Industry [PDF]

open access: yes
This paper deals with the links between the development of new drugs, and particularly of innovative new drugs, and the international activities of U.S. drug companies. While U.S.
Benjamin I. Cohen   +2 more
core  

Pharmacological Interventions for Orthostatic Hypotension: A Systematic Review. [PDF]

open access: yesCureus
Verma A   +6 more
europepmc   +1 more source

Changes in Gait Speed Vary Widely after the Use of Antiparkinson Medication in Persons with Parkinson's Disease. [PDF]

open access: yesMov Disord Clin Pract
Rosenfeldt AB   +10 more
europepmc   +1 more source

Adamantine Amantadine. [PDF]

open access: yesJ Gen Intern Med
Acosta LMY.
europepmc   +1 more source

Dyskinesia-Hyperpyrexia Syndrome in Parkinson's Disease May Benefit from GPi Deep Brain Stimulation: A Case Report. [PDF]

open access: yesTremor Other Hyperkinet Mov (N Y)
Huang SS   +10 more
europepmc   +1 more source

Medication improves velocity, reaction time, and movement time but not amplitude or error during memory-guided reaching in Parkinson's disease. [PDF]

open access: yesPhysiol Rep
Trevarrow MP   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy